Paliperidone | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Paliperidone
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Paliperidone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

43 API Suppliers, 26 USDMF, 9 EU WC, 3 KDMF, 14 NDC API, 22 Listed Suppliers, $ API Reference Price

43 API Suppliers
26 USDMF
9 EU WC
3 KDMF
14 NDC API
22 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

20 Intermediate Suppliers

20 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

347 FDF Dossiers, 56 FDA Orange Book, 233 Europe, 3 Canada, 14 Australia, 7 South Africa, 34 Listed Dossiers

347 FDF Dossiers
56 FDA Orange Book
233 Europe
3 Canada
14 Australia
7 South Africa
34 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 3MG, TABLET, EXTENDED RELEASE;ORAL - 6MG, TABLET, EXTENDED RELEASE;ORAL - 9MG

TABLET, EXTENDED RELEASE;ORAL - 1.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 3MG
TABLET, EXTENDED RELEASE;ORAL - 6MG
TABLET, EXTENDED RELEASE;ORAL - 9MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 SPI Pharma, 13 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 22 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Esteem Industries, 2 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 20 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 4 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

47 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 22 Controlled & Modified Release, 16 Granulation, 14 Solubilizers, 14 Topical, 13 Thickeners and Stabilizers, 13 Lubricants & Glidants, 12 Film Formers & Plasticizers, 11 Direct Compression, 8 Parenteral, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 5 Emulsifying Agents, 4 Disintegrants & Superdisintegrants, 4 Vegetarian Capsules, 3 Co-Processed Excipients, 3 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 2 Taste Masking

47 Coating Systems & Additives
30 Fillers, Diluents & Binders
22 Controlled & Modified Release
16 Granulation
14 Solubilizers
14 Topical
13 Thickeners and Stabilizers
13 Lubricants & Glidants
12 Film Formers & Plasticizers
11 Direct Compression
8 Parenteral
5 Empty Capsules
5 API Stability Enhancers
5 Coloring Agents
5 Emulsifying Agents
4 Disintegrants & Superdisintegrants
4 Vegetarian Capsules
3 Co-Processed Excipients
3 Rheology Modifiers
2 Chewable & Orodispersible Aids
2 Taste Masking

DIGITAL CONTENT

33 News #PharmaBuzz

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

13 US Medicaid Prescriptions, 28 Regulatory FDF Prices, 3 Annual Reports

13 US Medicaid Prescriptions
28 Regulatory FDF Prices
3 Annual Reports

MARKET PLACE

11 APIs, 5 FDF Dossiers

11 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 Health Canada Patents

5 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 3 Others

1 USP
3 Others

ANALYTICAL

3 BioAnalytical Methods

3 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 43,818 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Blake Cassels & Graydon LLP

filter Patent Reset all filters

5 All

01 52494234

filter Product Reset all filters

5 All

01 5Paliperidone

filter Dosage Reset all filters

5 All

01 1Extended Release Tablet

02 2Extended Release Tablets

03 2Extended release tablets

filter Exp Date Reset all filters

5 All

01 52023-07-28

Interquim-Paliperidone-Popup

Product Main Page

01

Blake Cassels & Graydon LLP

Paliperidone

PackExpo

Not Confirmed

Blake Cassels & Graydon LLP

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Paliperidone

Brand Name : INVEGA

Patent Number : 2494234

Filing Date : 2003-07-28

Strength per Unit : 3 mg

Dosage Form : Extended release tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Blake Cassels & Graydon LLP

Paliperidone

PackExpo

Not Confirmed

Blake Cassels & Graydon LLP

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Paliperidone

Brand Name : INVEGA

Patent Number : 2494234

Filing Date : 2003-07-28

Strength per Unit : 6 mg

Dosage Form : Extended release tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Blake Cassels & Graydon LLP

Paliperidone

PackExpo

Not Confirmed

Blake Cassels & Graydon LLP

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Paliperidone

Brand Name : INVEGA

Patent Number : 2494234

Filing Date : 2003-07-28

Strength per Unit : 9 mg

Dosage Form : Extended Release Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Blake Cassels & Graydon LLP

Paliperidone

PackExpo

Not Confirmed

Blake Cassels & Graydon LLP

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Paliperidone

Brand Name : INVEGA

Patent Number : 2494234

Filing Date : 2003-07-28

Strength per Unit : 12 mg

Dosage Form : Extended Release Tablets

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Blake Cassels & Graydon LLP

Paliperidone

PackExpo

Not Confirmed

Blake Cassels & Graydon LLP

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Paliperidone

Brand Name : INVEGA

Patent Number : 2494234

Filing Date : 2003-07-28

Strength per Unit : 1.5 mg

Dosage Form : Extended Release Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-07-28

Date Granted : 2009-10-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!